Clinical Trial for Patients in the United States and Canada
Vertex Spring Trial

An Investigational Study for Patients With Acute Traumatic Spinal Cord Injury in the Neck

Acute Spinal Cord Injury Trial

Patients with recent acute traumatic spinal cord injury (SCI) in the neck area who will undergo decompression/stabilization surgery starting within 72 hours of injury may qualify for the SPRING Trial. The investigational therapy, VX-210, is applied to the spinal cord during the initial decompression/stabilization surgery.

Researchers are now evaluating the efficacy and safety of this investigational therapy. Participants who qualify and are enrolled in the trial will be assigned at random to receive VX-210 or a placebo. Participants will not know if they are being given the therapy or the placebo.

Follow-up evaluations are carried out for 12 months after treatment. Researchers will assess the efficacy and safety of VX-210.

Read more about key participation requirements for the SPRING Trial

This website contains information related to general medical conditions and is provided for educational purposes only. It is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

The study described here investigates treatments or outcomes that have not received regulatory approval from a health authority. The information presented here is not meant to convey conclusions of safety or effectiveness. There is no guarantee that the outcome of this trial will result in approval by a regulatory authority. The information about the SPRING Trial used in this website comes from ClinicalTrials.gov.